FDA Drug Recalls

Recalls / Class II

Class IID-0242-2018

Product

SPIRIVA HandiHaler (tiotropium bromide inhalation powder) 18 mcg/capsule (90 capsules (unit dose blisters) per box, Rx Only, Made in Germany, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0075-47

Brand name
Spiriva
Generic name
Tiotropium Bromide
Active ingredient
Tiotropium Bromide Monohydrate
Route
Oral, Respiratory (inhalation)
NDC
0597-0075
FDA application
NDA021395
Affected lot / code info
Lot # 606478; Exp. 03/18

Why it was recalled

Failed Stability Specifications

Recalling firm

Firm
Boehringer Ingelheim Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
900 Ridgebury Rd, Ridgefield, Connecticut 06877-1058

Distribution

Quantity
45,008 units/90 capsules each unit
Distribution pattern
Distributed nationwide

Timeline

Recall initiated
2017-12-14
FDA classified
2018-01-26
Posted by FDA
2018-02-07
Terminated
2018-10-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0242-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Spiriva · FDA Drug Recalls